SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-24-000165
Filing Date
2024-02-05
Accepted
2024-02-05 06:30:41
Documents
16
Period of Report
2024-02-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IDEXX LABORATORIES, INC. 8-K a53891750.htm   iXBRL 8-K 32594
2 EXHIBIT 99.1 a53891750ex99_1.htm EX-99.1 1171365
6 idexxlogo.jpg GRAPHIC 3406
  Complete submission text file 0001157523-24-000165.txt   1404150

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20240205.xsd EX-101.SCH 3857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20240205_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20240205_pre.xml EX-101.PRE 16039
18 EXTRACTED XBRL INSTANCE DOCUMENT a53891750_htm.xml XML 4063
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

IRS No.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 24593888
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)